LLMpediaThe first transparent, open encyclopedia generated by LLMs

penicilliosis

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Penicillium Hop 4
Expansion Funnel Raw 66 → Dedup 27 → NER 9 → Enqueued 8
1. Extracted66
2. After dedup27 (None)
3. After NER9 (None)
Rejected: 18 (not NE: 18)
4. Enqueued8 (None)
Similarity rejected: 1
penicilliosis
NamePenicilliosis
FieldInfectious disease, Mycology
CausesPenicillium marneffei
RisksHIV/AIDS, Immunosuppression
DiagnosisMicrobiological culture, Histopathology
TreatmentAmphotericin B, Itraconazole
FrequencySoutheast Asia

penicilliosis. Penicilliosis is a systemic fungal infection caused by the thermally dimorphic fungus Penicillium marneffei. It is a significant opportunistic infection, particularly among individuals with compromised immune systems, such as those with advanced HIV/AIDS. The disease is endemic to specific regions of Southeast Asia, including Thailand, Vietnam, and Southern China, and presents with a wide range of clinical manifestations often mimicking other illnesses like tuberculosis or histoplasmosis.

Overview

The causative agent, Penicillium marneffei, was first isolated in 1956 from the bamboo rat Rhizomys sinensis in Vietnam. The disease gained major medical recognition in the late 1980s with the burgeoning HIV/AIDS pandemic in Southeast Asia. Unlike other Penicillium species commonly found in the environment, this pathogen is a true human pathogen capable of causing disseminated infection. The World Health Organization classifies it as a priority fungal pathogen due to its high mortality in untreated, immunocompromised populations. Its epidemiology is closely tied to specific ecological niches within the Mekong River region.

Causes and transmission

Infection is caused exclusively by the inhalation of airborne conidia from the environmental mold form of Penicillium marneffei. The natural habitat of the fungus is believed to be soil, particularly in areas associated with bamboo rats like Rhizomys sumatrensis and Cannomys badius, though these animals are considered incidental hosts rather than a direct source of human infection. Transmission does not occur from person to person. The primary risk factor is profound cellular immunodeficiency, most notably from advanced HIV/AIDS, especially with CD4 counts below 100 cells/µL. Other risk conditions include hematologic malignancies, organ transplantation, and therapies involving corticosteroids or TNF-alpha inhibitors.

Clinical presentation

The disease often presents with nonspecific, systemic symptoms. Common features include prolonged fever, significant weight loss, and generalized lymphadenopathy. A highly characteristic cutaneous manifestation is the presence of umbilicated papules, resembling those seen in molluscum contagiosum, often on the face and upper trunk. Patients frequently have hepatosplenomegaly and respiratory symptoms such as cough and dyspnea, which can lead to confusion with pneumocystis pneumonia or miliary tuberculosis. Dissemination can involve the bone marrow, liver, and gastrointestinal tract, leading to anemia and fungemia.

Diagnosis

Definitive diagnosis relies on the isolation and identification of Penicillium marneffei from clinical specimens. Gold standard methods include microbiological culture of samples from blood, bone marrow, skin lesions, or lymph node biopsies, which shows a characteristic dimorphic transition from mold at 25°C to a yeast-like form at 37°C. Direct microscopic examination of Giemsa-stained or Wright-stained smears from lesions can reveal intracellular, sausage-shaped yeast cells with central septation. Serological tests, such as assays for galactomannan, can be supportive. Histopathological examination of tissue biopsies often shows granulomatous or suppurative inflammation.

Treatment and prevention

Initial therapy for severe infection typically involves intravenous amphotericin B, often the liposomal formulation, for a two-week induction phase. This is followed by consolidation and maintenance therapy with oral itraconazole for a minimum of ten weeks. For patients with HIV/AIDS, secondary prophylaxis with itraconazole is recommended until immune reconstitution is achieved through effective antiretroviral therapy, such as regimens containing tenofovir or efavirenz. Primary prevention with itraconazole may be considered for high-risk individuals residing in endemic areas. There is no available vaccine.

Epidemiology

Penicilliosis is geographically restricted to Southeast Asia and parts of South Asia. It is highly endemic in northern Thailand, especially Chiang Mai Province, Vietnam, Hong Kong, and the Guangxi region of Southern China. Cases have also been reported in Taiwan, India (particularly Manipur), and Singapore. The incidence rose dramatically as a major AIDS-defining illness in these regions during the 1990s. With the scale-up of antiretroviral therapy, the incidence has declined but it remains an important cause of morbidity and mortality among those with undiagnosed HIV or poor access to healthcare. Travel-associated cases are occasionally reported in non-endemic countries like the United States or Australia.

Category:Fungal diseases Category:Opportunistic infections Category:Tropical diseases